<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">J Addict Med</journal-id><journal-id journal-id-type="iso-abbrev">J Addict Med</journal-id><journal-id journal-id-type="pmc-domain-id">3836</journal-id><journal-id journal-id-type="pmc-domain">phewolters</journal-id><journal-id journal-id-type="publisher-id">JAM</journal-id><journal-title-group><journal-title>Journal of Addiction Medicine</journal-title></journal-title-group><issn pub-type="ppub">1932-0620</issn><issn pub-type="epub">1935-3227</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>Wolters Kluwer - PMC COVID-19 Collection</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10022523</article-id><article-id pub-id-type="pmcid-ver">PMC10022523.1</article-id><article-id pub-id-type="pmcaid">10022523</article-id><article-id pub-id-type="pmcaiid">10022523</article-id><article-id pub-id-type="pmid">36129690</article-id><article-id pub-id-type="doi">10.1097/ADM.0000000000001079</article-id><article-id pub-id-type="publisher-id">JAM_220194</article-id><article-version-alternatives><article-version article-version-type="pmc-version">1</article-version><article-version vocab="JAV" vocab-identifier="http://www.niso.org/publications/rp/RP-8-2008.pdf" article-version-type="Version of Record">3</article-version></article-version-alternatives><article-categories><subj-group subj-group-type="heading"><subject>Original Research</subject></subj-group></article-categories><title-group><article-title>Implementation of Telemedicine Delivery of Medications for Opioid Use Disorder in Pennsylvania Treatment Programs During COVID-19</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Poulsen</surname><given-names initials="MN">Melissa N.</given-names></name><degrees>PhD, MPH</degrees></contrib><contrib contrib-type="author"><name name-style="western"><surname>Santoro</surname><given-names initials="W">William</given-names></name><degrees>MD</degrees><email>william.santoro@towerhealth.org</email></contrib><contrib contrib-type="author"><name name-style="western"><surname>Scotti</surname><given-names initials="R">Roseanne</given-names></name><degrees>JD</degrees><email>c-rscotti@pa.gov</email></contrib><contrib contrib-type="author"><name name-style="western"><surname>Henderson</surname><given-names initials="C">Catherine</given-names></name><degrees>LCSW</degrees><email>chenderson6@wellspan.org</email></contrib><contrib contrib-type="author"><name name-style="western"><surname>Ruddy</surname><given-names initials="M">Meaghan</given-names></name><degrees>PhD</degrees><email>ruddym@thewrightcenter.org</email></contrib><contrib contrib-type="author"><name name-style="western"><surname>Colistra</surname><given-names initials="A">Angela</given-names></name><degrees>PhD, LPC, CAADC, CCS</degrees><email>angela.colistra@lvhn.org</email></contrib></contrib-group><aff>From the Department of Population Health Sciences, Geisinger, Danville, PA (MNP); Section of Addiction Medicine, Tower Health System, Reading, PA (WS); Vital Strategies, New York, NY (RS); Pennsylvania Department of Health, Harrisburg, PA (RS); Department of Addiction Services, WellSpan Health, York, PA (CH); The Wright Centers for Community Health and Graduate Medical Education, Scranton, PA (MR); AT Still University School of Osteopathic Medicine in Arizona, Mesa, AZ (MR); Department of Family Medicine, Lehigh Valley Health Network, Allentown, PA (AC); and Morsani College of Medicine, University of South Florida, North Tampa, FL (AC).</aff><author-notes><corresp id="corr1">Send correspondence to Melissa N. Poulsen, PhD, MPH, Department of Population Health Sciences, Geisinger, 100 N Academy Ave, Danville, PA 17822. E-mail: <email>mpoulsen@geisinger.edu</email>.</corresp></author-notes><pub-date pub-type="ppub"><season>Mar-Apr</season><year>2023</year></pub-date><pub-date pub-type="epub"><day>19</day><month>9</month><year>2022</year></pub-date><volume>17</volume><issue>2</issue><issue-id pub-id-type="pmc-issue-id">431520</issue-id><fpage>e110</fpage><lpage>e118</lpage><history><date date-type="received"><day>1</day><month>7</month><year>2022</year></date><date date-type="accepted"><day>4</day><month>8</month><year>2022</year></date></history><pub-history><event event-type="pmc-release"><date><day>19</day><month>09</month><year>2022</year></date></event><event event-type="pmc-live"><date><day>17</day><month>03</month><year>2023</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-02-13 18:43:44.060"><day>13</day><month>02</month><year>2024</year></date></event></pub-history><permissions><copyright-statement>Copyright &#169; 2022 American Society of Addiction Medicine</copyright-statement><copyright-year>2022</copyright-year><copyright-holder>Wolters Kluwer Health, Inc. All rights reserved.</copyright-holder><license><license-p>This article is made available via the PMC Open Access Subset for unrestricted re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the COVID-19 pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections. </license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="jam-17-e110.pdf"/><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="jam-17-e110.pdf"/><abstract><title>Introduction</title><p>Temporary policy changes during the coronavirus disease 2019 pandemic facilitated rapid expansion of medication for opioid use disorder via telemedicine (tele-MOUD). Evidence for tele-MOUD best practices and its impact on treatment engagement and retention remains limited. This quality improvement initiative compared tele-MOUD implementation among Pennsylvania medication for opioid use disorder (MOUD) programs, evaluated sociodemographic characteristics of patients using tele-MOUD, and described trends in tele-MOUD use and patient engagement and retention.</p><sec><title>Methods</title><p>Five health systems with MOUD programs completed questionnaires regarding their tele-MOUD models and provided aggregated sociodemographic data for MOUD patients with in-person and telemedicine visits in 2020. Three programs provided aggregated monthly appointment data (scheduled, completed, no-show, tele-MOUD visits) over the period in which tele-MOUD scaled up.</p></sec><sec><title>Results</title><p>Differences in tele-MOUD protocols related to provision of tele-MOUD inductions, patient eligibility for tele-MOUD, and operationalization of remote drug testing. Across programs, 88% of prescribers conducted tele-MOUD appointments, and 50% of patients used tele-MOUD in 2020. We observed sociodemographic differences, with a greater proportion of female, White, and non-Hispanic patients using tele-MOUD. Across programs with appointment data, overall patient enrollment increased, and new patient enrollment remained relatively constant. Engagement trends suggested a temporary decline in no-show appointments that aligned with the escalation of tele-MOUD in one program.</p></sec><sec><title>Conclusions</title><p>Tele-MOUD protocol differences indicate a need for research to inform evidence-based guidance. Findings suggest that patients largely remained engaged and retained in MOUD as tele-MOUD was implemented but reveal inequities in tele-MOUD use, highlighting the need for efforts to overcome technology access barriers and avoid exacerbating disparities in MOUD access.</p></sec></abstract><kwd-group><title>Key Words</title><kwd>addiction medicine</kwd><kwd>buprenorphine</kwd><kwd>opioid-related disorders</kwd><kwd>rural health services</kwd><kwd>telemedicine</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>STATUS</meta-name><meta-value>ONLINE-ONLY</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>